in the news

Recent Rosacea Blog Posts

Rosacea coverage at AAD Denver 2014

The annual meeting of the American Academy of Dermatology is to be held in March in Denver, Colorado. The popularity of the  topic of rosacea seems to have waxed and waned over the years. This year there are mentions in keynote and symposium sessions for rosacea. It doesn’t seem like rosacea will have much of […]

Continue Reading

Why are drugs so much cheaper from Pharmacies in Canada?

The topic of ordering cheap prescriptions from Canada comes up every now and then on rosacea bulletin boards. The price difference over the border is enough to make anyone paying full price scream. So what is the reason for this price difference, and is it worth trying to source prescriptions from a country that you […]

Continue Reading

Mirvaso Rebound Flushing makes the news

In a followup article on François Fournier, the head of Galderma USA, the Dallas Forth Worth Daily raises the topic of rebound flushing from Mirvaso. Whilst only quoting one online forum posting, the author Bradford Pearson highlights what he calls the mixed response to the newly released topical Mirvaso. Indeed it is a question that […]

Continue Reading

Mirvaso to be a $100 million drug for Galderma

A revealing interview with the Galderma USA President Francois Fournier has just been published by the Dallas Fort Worth Healthcare Daily. This publication, `D HEALTHCARE Daily’ takes a keen interest in Galderma as the company’s US headquarters are in Forth Worth, TX. In the interview Fournier gives some interesting insights into the research and development […]

Continue Reading

American Acne & Rosacea Society, too close to Big Pharma ?

A really interesting post over at `medpage TODAY’ is asking just what is the American Acne & Rosacea Society is up to, and asking the question are they too close to the bigPharma that they are funded by. We first learned of the existence of the AARS in 2006. Whilst it was puzzling as to […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.